These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 28717382)

  • 1. Neurological soft signs in Tunisian patients with first-episode psychosis and relation with cannabis use.
    Mhalla A; Ben Mohamed B; Correll CU; Amamou B; Mechri A; Gaha L
    Ann Gen Psychiatry; 2017; 16():30. PubMed ID: 28717382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Minor neurological and physical anomalies in patients with first-episode psychosis].
    Mhalla A; Boussaïd N; Gassab L; Gaha L; Mechri A
    Encephale; 2013 Jun; 39(3):149-54. PubMed ID: 23095597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neurological soft signs in early onset schizophrenia].
    Bourgou Gaha S; Halayem Dhouib S; Amado I; Bouden A
    Encephale; 2015 Jun; 41(3):209-14. PubMed ID: 24854724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fewer neurological soft signs among first episode psychosis patients with heavy cannabis use.
    Ruiz-Veguilla M; Gurpegui M; Barrigón ML; Ferrín M; Marín E; Rubio JL; Gutiérrez B; Pintor A; Cervilla J
    Schizophr Res; 2009 Feb; 107(2-3):158-64. PubMed ID: 18805673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neurological soft signs in schizophrenic patients and their nonaffected siblings].
    Mechri A; Slama H; Bourdel MC; Chebel S; Mandhouj O; Krebs MO; Gaha L
    Encephale; 2008 Oct; 34(5):483-9. PubMed ID: 19068337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heavy cannabis use prior psychosis in schizophrenia: clinical, cognitive and neurological evidences for a new endophenotype?
    Mallet J; Ramoz N; Le Strat Y; Gorwood P; Dubertret C
    Eur Arch Psychiatry Clin Neurosci; 2017 Oct; 267(7):629-638. PubMed ID: 28190094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological soft signs in non-psychotic patients with cannabis dependence.
    Dervaux A; Bourdel MC; Laqueille X; Krebs MO
    Addict Biol; 2013 Mar; 18(2):214-21. PubMed ID: 21054691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurological soft signs in first-episode psychosis: a systematic review.
    Dazzan P; Murray RM
    Br J Psychiatry Suppl; 2002 Sep; 43():s50-7. PubMed ID: 12271801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurological soft signs in obsessive-compulsive disorder: the effect of co-morbid psychosis and evidence for familiality.
    Peng ZW; Xu T; Miao GD; He QH; Zhao Q; Dazzan P; Chan RC
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):200-5. PubMed ID: 22735396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurological soft signs in first-episode schizophrenia: State- and trait-related relationships to psychopathology, cognition and antipsychotic medication effects.
    Emsley R; Chiliza B; Asmal L; Kilian S; Riaan Olivier M; Phahladira L; Ojagbemi A; Scheffler F; Carr J; Kidd M; Dazzan P
    Schizophr Res; 2017 Oct; 188():144-150. PubMed ID: 28130002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Cannabis Pathway to Non-Affective Psychosis may Reflect Less Neurobiological Vulnerability.
    Løberg EM; Helle S; Nygård M; Berle JØ; Kroken RA; Johnsen E
    Front Psychiatry; 2014; 5():159. PubMed ID: 25477825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurological signs and morphological cerebral changes in schizophrenia: An analysis of NSS subscales in patients with first episode psychosis.
    Heuser M; Thomann PA; Essig M; Bachmann S; Schröder J
    Psychiatry Res; 2011 May; 192(2):69-76. PubMed ID: 21498055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurological soft signs discriminate schizophrenia from major depression but not bipolar disorder.
    Zhao Q; Ma YT; Lui SS; Liu WH; Xu T; Yu X; Tan SP; Wang ZR; Qu M; Wang Y; Huang J; Cheung EF; Dazzan P; Chan RC
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun; 43():72-8. PubMed ID: 23266480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adaptation and validation of the neurological soft sign's scale of Krebs et al. to children].
    Halayem S; Hammami M; Fakhfakh R; Gaddour N; Tabbane K; Amado I; Krebs MO; Bouden A
    Encephale; 2017 Apr; 43(2):128-134. PubMed ID: 27349580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential contributions of brainstem structures to neurological soft signs in first- and multiple-episode schizophrenia spectrum disorders.
    Fritze S; Bertolino AL; Kubera KM; Topor CE; Schmitgen MM; Wolf RC; Hirjak D
    Schizophr Res; 2019 Aug; 210():101-106. PubMed ID: 31178363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors, pre-morbid functioning and episode correlates of neurological soft signs in drug-naive patients with schizophrenia-spectrum disorders.
    Peralta V; de Jalón EG; Campos MS; Basterra V; Sanchez-Torres A; Cuesta MJ
    Psychol Med; 2011 Jun; 41(6):1279-89. PubMed ID: 20860873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal study of neurological soft signs in first-episode early-onset psychosis.
    Mayoral M; Bombín I; Castro-Fornieles J; González-Pinto A; Otero S; Parellada M; Moreno D; Baeza I; Graell M; Rapado M; Arango C
    J Child Psychol Psychiatry; 2012 Mar; 53(3):323-31. PubMed ID: 22023091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlations of cerebello-thalamo-prefrontal structure and neurological soft signs in patients with first-episode psychosis.
    Mouchet-Mages S; Rodrigo S; Cachia A; Mouaffak F; Olie JP; Meder JF; Oppenheim C; Krebs MO
    Acta Psychiatr Scand; 2011 Jun; 123(6):451-8. PubMed ID: 21219267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurological soft signs in adolescents with first episode psychosis.
    Zabala A; Robles O; Parellada M; Moreno DM; Ruiz-Sancho A; Burdalo M; Medina O; Arango C
    Eur Psychiatry; 2006 Jul; 21(5):283-7. PubMed ID: 16360308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurological soft signs (NSS) and brain morphology in patients with chronic schizophrenia and healthy controls.
    Herold CJ; Essig M; Schröder J
    PLoS One; 2020; 15(4):e0231669. PubMed ID: 32320431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.